| Literature DB >> 27747200 |
Silvia Bini1, Cesare Cerri2, Antonello E Rigamonti1, Pietro A Bertazzi1, Gianfrancesco Fiorini1, Silvano G Cella1.
Abstract
We analysed drug dispensation by charitable organisations in a year time. Drugs were grouped according to the Anatomic Therapeutic Chemical classification and the amount dispensed was calculated with the system of the Daily Defined Dose (DDD) and expressed as DDD/1000 subjects/day. A number of 87,550 subjects were studied (13,308 Italians; 74,242 Immigrants). Though we noticed a great sesonal variability, the drugs most frequently dispensed were those for the respiratory, cardiovascular and gastrointestinal system and antibiotics, which is different from the rest of the Italian population and the immigrant population assisted by our National Health Service (NHS). We also found that chronic diseases are increasing in these subjects. We conclude that the subjects not receiving NHS assitance have, at least in part, different health patterns and requirements. This should be considered when planning tailored interventions.Entities:
Keywords: Drug dispensation; Health needs; Immigrants; Pharmacoepidemiology
Year: 2016 PMID: 27747200 PMCID: PMC5062753 DOI: 10.4081/jphr.2016.623
Source DB: PubMed Journal: J Public Health Res ISSN: 2279-9028
Principal anatomical therapeutic chemical (ATC) categories of pharmaceutical products prescribed by the centers from January to December 2014. ATC classes that were rarely or never prescribed are not shown.
| ATC category | DDD/1000 patients/day | Therapeutical groups most commonly prescribed |
|---|---|---|
| A) Alimentary tract and metabolism | 8.7 | Antiulcer (peptic) and GORD; stomatological preparations; hypoglycaemic agents |
| B) Blood and blood forming organs | 1.0 | Antithrombotic agents; Iron Preparations; vitamin B12 and folic aAcid |
| C) Cardiovascular system | 11.1 | Cholesterol-lowering; ACE inhibitors; beta blocking agents |
| D) Dermatologicals | 0.2 | Antiseptics and disinfectants; emollients and protective; antifungals for topical use |
| G) Genitourinary system and sex hormones | 0.7 | Drugs for benign prostatic hypertrophy; progestogens; Eestrogens |
| H) Systemic hormones (excl. sex hormones) | 0.7 | Corticosteroids for systemic use; thyroid preparations; antithyroid preparations |
| J) Anti-infectives for systemic use | 2.8 | Beta-lactam; penicilins; quinolones; macrolids; lincosamides and streptogramins |
| L) Antineoplastic and immunomodulators | 0.2 | Immunosuppressants; hormone antagonists and related agents; hormones and related agents |
| M) Musculo-skeletal system | 2.1 | NSAIDs; antigout preparations; drugs affecting bone structure and mineralization |
| N) Central nervous system | 1.2 | Antidepressants; antiepileptics; dopaminergic agents |
| R) Respiratory system | 12.2 | Decongestants and other nasal and throat preparations for topical use; expectorants |
| S) Sensory organs | 0.3 | Antiglaucoma and miotics |
Characteristics of the population.
| Characteristics | % |
|---|---|
| Gender | |
| Males | 61.3 |
| Females | 38.7 |
| Age distribution | |
| Minors (<17 years) | 13.0 |
| Adults (18-65 years) | 75.3 |
| Elderly (>65 years) | 11.7 |
| Geographical region of birth | |
| Italy | 15.2 |
| Maghreb | 26.0 |
| Eastern Europe | 24.4 |
| Sub-Saharan Africa | 13.0 |
| Latin America | 7.8 |
| Central and Eastern Asia | 7.2 |
| Middle East | 2.7 |
| Other origin | 3.7 |
| Disease duration | |
| Acute | 54.4 |
| Chronic | 45.6 |